EDAP TMS (EDAP) Stock Price, News & Analysis

Company Overview

Edap Tms SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi.

Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States. Beyond product sales, the company provides comprehensive training programs for urologists, ongoing service and maintenance support, and collaborates with clinical centers on research initiatives to refine treatment protocols and expand indications.

Edap Tms serves a global customer base through a network of direct subsidiaries and independent distributors across North America, Europe, Latin America and Asia. Its devices are installed in academic hospitals, cancer treatment centers and specialized urology clinics, reflecting broad adoption of noninvasive therapies as alternatives to open or laparoscopic surgery. The company continues to invest in R&D to enhance image-guided accuracy, reduce treatment times and explore next-generation applications of focused energy in urology.

Key Stats

• Today's Range: $2.43 to $2.66
• 50-Day Range: $1.25 to $2.80
• 52-Week Range: $1.21 to $3.29
• Volume: 52,447 shs
• Average Volume: 175,244 shs
• Market Capitalization: $91.61 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $8.50
• Consensus Rating: Hold

EDAP TMS Stock Analysis - MarketRank™

EDAP TMS scored higher than 45% of companies evaluated by MarketBeat, and ranked 695th out of 958 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Hold

Consensus Rating

EDAP TMS has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

Upside Potential

EDAP TMS has a consensus price target of $8.50, representing about 246.9% upside from its current price of $2.45.

Amount of Analyst Coverage

EDAP TMS has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for EDAP TMS are expected to grow in the coming year, from ($0.60) to ($0.48) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of EDAP TMS is -4.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of EDAP TMS is -4.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

EDAP TMS has a P/B Ratio of 2.08. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.44% of the float of EDAP TMS has been sold short.

Short Interest Ratio / Days to Cover

EDAP TMS has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in EDAP TMS has recently increased by 141.35%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

EDAP TMS does not currently pay a dividend.

Dividend Growth

EDAP TMS does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.44% of the float of EDAP TMS has been sold short.

Short Interest Ratio / Days to Cover

EDAP TMS has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in EDAP TMS has recently increased by 141.35%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.5 / 5
• News Sentiment: 0.52

News Sentiment

EDAP TMS has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.92 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for EDAP TMS this week, compared to 2 articles on an average week.

MarketBeat Follows

2 people have added EDAP TMS to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, EDAP TMS insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.23% of the stock of EDAP TMS is held by insiders.

Percentage Held by Institutions

62.74% of the stock of EDAP TMS is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

EDAP Stock Analysis - Frequently Asked Questions

How have EDAP shares performed this year?

EDAP TMS's stock was trading at $2.21 at the beginning of 2025. Since then, EDAP stock has increased by 10.9% and is now trading at $2.45.

How were EDAP TMS's earnings last quarter?

EDAP TMS S.A. (NASDAQ:EDAP) issued its earnings results on Thursday, May, 15th. The medical equipment provider reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by $0.04. The medical equipment provider had revenue of $16.37 million for the quarter, compared to the consensus estimate of $16.56 million. EDAP TMS had a negative trailing twelve-month return on equity of 56.85% and a negative net margin of 33.49%.
Read the conference call transcript.

Who are EDAP TMS's major shareholders?

EDAP TMS's top institutional shareholders include Sage Mountain Advisors LLC (0.27%), Simplicity Wealth LLC (0.09%), BNP Paribas Financial Markets (0.07%) and Group One Trading LLC.

How do I buy shares of EDAP TMS?

Shares of EDAP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of EDAP TMS own?

Based on aggregate information from My MarketBeat watchlists, some other companies that EDAP TMS investors own include Energous (WATT), Weatherford International (WFT), CTI BioPharma (CTIC), Petroleo Brasileiro S.A.- Petrobras (PBR), Advanced Micro Devices (AMD), Kandi Technologies Group (KNDI) and NVIDIA (NVDA).

Company Calendar

• Last Earnings: 5/15/2025
• Today: 9/13/2025
• Next Earnings (Estimated): 11/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:EDAP
• CIK: 1041934
• Web: www.edap-tms.com
• Phone: (347) 215-3150
• Fax: 33-04-72-15-31-51
• Employees: 230
• Year Founded: 1979

Price Target and Rating

• Average Price Target for EDAP TMS: $8.50
• High Price Target: $19.00
• Low Price Target: $2.00
• Potential Upside/Downside: +246.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.61)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$20.58 million
• Net Margins: -33.49%
• Pretax Margin: -33.00%
• Return on Equity: -56.85%
• Return on Assets: -26.83%

Debt

• Debt-to-Equity Ratio: 0.04
• Current Ratio: 1.51
• Quick Ratio: 1.05

Sales & Book Value

• Annual Sales: $69.18 million
• Price / Sales: 1.32
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.18 per share
• Price / Book: 2.08

Miscellaneous

• Outstanding Shares: 37,390,000
• Free Float: 37,306,000
• Market Cap: $91.61 million
• Optionable: Optionable
• Beta: -0.21